XenoTherapeutics is a not-for-profit, clinical-stage regenerative medicine company developing innovative cell and tissue-based research solutions. Our FDA-accepted pathogen screening and validated assays provide a robust regulatory pathway for the clinical advancement of xenogeneic cells, tissues, and organs. We accelerate the development, testing, training, and commercialization of innovative, live biotherapeutic products that deliver on the promise of regenerative medicine.